Maxair: What Should I Tell My Healthcare Provider?
Maxair inhalers will not be made, dispensed, or sold in the United States in their current form after December 31, 2013. Maxair contains chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. The manufacturer of Maxair is working on a reformulated, CFC-free version, although it is not yet clear when that product will be available to consumers.
You should talk with your healthcare provider prior to taking Maxair
® (
pirbuterol acetate) if you have:
Also let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
- Breastfeeding.
You should also make sure to tell your healthcare provider about all other medicines you may be taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.